Cargando…

Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825443/ https://www.ncbi.nlm.nih.gov/pubmed/35154642 http://dx.doi.org/10.1002/clt2.12120

Ejemplares similares

High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
por: Madsen, Hanne, et al.
Publicado: (2021)

Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria
por: Sánchez-Borges, Mario, et al.
Publicado: (2014)

Up-dosing of non-sedating antihistamines in chronic urticaria: Need for well-designed clinical trials in India
por: Patil, Anant D.
Publicado: (2014)

269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Features of Antihistamine-Resistant Chronic Urticaria and Chronic Urticaria During Exacerbation
por: Huilan, Zhu, et al.
Publicado: (2015)

Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
por: Song, Xiaoting, et al.
Publicado: (2023)

Corrigendum to “High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI”
por: Ahmed, Sheikh Sohail, et al.
Publicado: (2015)

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017)

Cost‐effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria
por: Denman, Sarah, et al.
Publicado: (2022)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
por: Kim, Mi-Ae, et al.
Publicado: (2023)

Expert consensus on the use of omalizumab in chronic urticaria in China()
por: Zhao, Zuotao, et al.
Publicado: (2021)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Drug eruption by antihistamine mistaken for chronic urticaria in a child
por: Lee, Gun Moo, et al.
Publicado: (2019)

274 Vasculitic Urticaria Treated with Omalizumab. Case Report
por: Ramírez Del Pozo, María Elena, et al.
Publicado: (2012)

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H(1) Antihistamines: A Randomized, Placebo-Controlled Study
por: Saini, Sarbjit S, et al.
Publicado: (2015)

281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
por: Comberiati, Pasquale, et al.
Publicado: (2019)

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023)

T cell activity in successful treatment of chronic urticaria with omalizumab
por: Sánchez-Machín, Inmaculada, et al.
Publicado: (2011)

Omalizumab therapy in three patients with chronic autoimmune urticaria
por: Al-Ahmad, Mona
Publicado: (2010)

Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
por: Nam, Young-Hee, et al.
Publicado: (2012)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Treating chronic urticaria refractory to H1-antihistamines in Russia: data from the AWARE study
por: Danilycheva, Inna, et al.
Publicado: (2022)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

Autologous Serum Therapy in Chronic Urticaria: A Promising Complement to Antihistamines
por: Debbarman, Panchami, et al.
Publicado: (2014)

Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn’s Disease
por: Barni, Simona, et al.
Publicado: (2021)

Cost-Minimization Analysis of Dexmedetomidine Compared to Other Sedatives for Short-Term Sedation During Mechanical Ventilation in the United States [Corrigendum]
Publicado: (2020)

Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
por: Ivyanskiy, Ilya, et al.
Publicado: (2012)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
por: Dekkers, Coco, et al.
Publicado: (2021)

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
por: Kara, Rabia Oztas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_74brt68n61hb51fd1bgmi3lr80